David Lehman

TitleAssociate Clinical Professor
InstitutionUniversity of California San Diego
Address9500 Gilman Drive #9116A
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Overview


    Dr. Lehman received his medical degree from Washington University in St. Louis Medical School and then completed his Psychiatry Residency at UCSD. He is currently Chief of the Cognitive Disorders Clinic at the VA Medical Center in San Diego as well as Medical Director of the Inpatient Unit. He is heavily involved in education in both the UCSD medical school as well as the residency training program, having won teaching awards in both departments. He is Associate Director for the third year Medical Student Psychiatry Clerkship and coordinates all of the fourth year Medical Student Psychiatry Sub-internships.

    Research Interests

    Dr. Lehman specializes in the treatment and management of psychotic disorders He is the Associate Director for medical student education in the Department of Psychiatry for both the third year and fourth year medical students.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Langley-DeGroot M, Joshi Y, Lehman D, Rao S. Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report. J Clin Psychopharmacol. 2016 Jun; 36(3):277-9. PMID: 27043124.
      View in: PubMed
    2. Wetherell JL, Afari N, Rutledge T, Sorrell JT, Stoddard JA, Petkus AJ, Solomon BC, Lehman DH, Liu L, Lang AJ, Atkinson JH. A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain. Pain. 2011 Sep; 152(9):2098-107. PMID: 21683527.
      View in: PubMed
    3. Zisook S, Kasckow JW, Golshan S, Fellows I, Solorzano E, Lehman D, Mohamed S, Jeste DV. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial. J Clin Psychiatry. 2009 Apr; 70(4):562-71. PMID: 19192468.
      View in: PubMed
    4. Montross LP, Kasckow J, Golshan S, Solorzano E, Lehman D, Zisook S. Suicidal ideation and suicide attempts among middle-aged and older patients with schizophrenia spectrum disorders and concurrent subsyndromal depression. J Nerv Ment Dis. 2008 Dec; 196(12):884-90. PMID: 19077855.
      View in: PubMed
    5. Zisook S, Montross L, Kasckow J, Mohamed S, Palmer BW, Patterson TL, Golshan S, Fellows I, Lehman D, Solorzano E. Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia. Am J Geriatr Psychiatry. 2007 Dec; 15(12):1005-14. PMID: 18056819.
      View in: PubMed
    6. Zisook S, Nyer M, Kasckow J, Golshan S, Lehman D, Montross L. Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression. Schizophr Res. 2006 Sep; 86(1-3):226-33. PMID: 16750346.
      View in: PubMed
    7. Meyer JM, Lehman D. Bone mineral density in male schizophrenia patients: a review. Ann Clin Psychiatry. 2006 Jan-Mar; 18(1):43-8. PMID: 16517452.
      View in: PubMed
    8. Lehman D, Meyer JM. Decreased bone mineral density in male schizophrenia patients. Schizophr Res. 2005 Jul 01; 76(1):131-3. PMID: 15927809.
      View in: PubMed